Kazia Therapeutics Limited - American Depositary Shares (KZIA)
10.23
-0.04 (-0.42%)
NASDAQ · Last Trade: Jul 18th, 10:15 AM EDT
Detailed Quote
Previous Close
10.27
Open
10.00
Bid
10.04
Ask
10.20
Day's Range
10.00 - 10.23
52 Week Range
2.860 - 39.05
Volume
1,284
Market Cap
1.35B
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
N/A (N/A)
1 Month Average Volume
650,404
Chart
About Kazia Therapeutics Limited - American Depositary Shares (KZIA)
Kazia Therapeutics is a biotechnology company focused on developing innovative cancer therapies, particularly for difficult-to-treat brain tumors and other malignancies. The company is dedicated to advancing its promising drug candidates through clinical trials, utilizing cutting-edge research and technology to improve patient outcomes. By harnessing the potential of novel compounds, Kazia aims to address significant unmet medical needs in oncology, striving to offer new hope to patients battling various forms of cancer. Read More
Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.
The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
As the US market prepares to open on Wednesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Kazia on Wednesday announced positive preclinical data for its paxalisib drug in triple-negative breast cancer. The company's stock is soaring over 77% on exceptionally high and unusual trading volume.
A new wave of innovation is reshaping small-cap markets across sectors including oncology, functional energy beverages, neuromodulation, crypto treasuries, advanced connectivity, and AI fitness. The following publicly traded companies—each under $5 per share—are generating increased investor attention with transformative developments.
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
